Hamilton James C's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Aug 15, 2025
- Accession no.
- 0001830755-25-000005
- Filed
- Aug 15, 2025
- Trade date
- Aug 13-15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $200.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hamilton James CCIK 0001830755 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Common Stock | SSaleDisposed | −611 | $20.00 | −$12,220 | 271,511 | Direct | |
| Aug 15, 2025 | Common Stock | SSaleDisposed | −9,389 | $20.00 | −$187,780 | 262,122 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.